Olga S. Khodorovich

Olga S. Khodorovich

Auto-generated profile, based on publicly available information

Olga S. Khodorovich

Russian Research Center of Radiology, Ministry of Health of Russia

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 August 2023 in Journal of radiology and nuclear medicine
Verified
Journal Article
Open access
PDF file
VSV. A. Solodkiy
V. A. Solodkiy
AKAndrei Kaprin
Andrei Kaprin
NNN. V. Nudnov
N. V. Nudnov
NKN. V. Kharchenko
N. V. Kharchenko
OKO. S. Khodorovich
O. S. Khodorovich
LKL. B. Kanakhina
L. B. Kanakhina
The relevance of implementing artificial intelligence (AI) technologies in the diagnosis of breast cancer (BC) is associated with a continuing high increase in BC incidence among women and its leading position in the structure of cancer incidence. Theoretically, using AI technologies is possible both at the stage of screening and in clarifying BC diagnosis. The article provides a brief overview of AI systems used in clinical practice and discusses their prospects in BC diagnosis. Advances in machine learning can be effective to improve the accuracy of mammography screening by reducing missed cancer cases and false positives.

1 January 2022 in Plastic Surgery and Aesthetic Medicine
Verified
Journal Article
Closed access
OKO.S. Khodorovich
O.S. Khodorovich
VSV.A. Solodkiy
V.A. Solodkiy
KSK.D. Sarkisyan
K.D. Sarkisyan
AKA.A. Kalinina-Masri
A.A. Kalinina-Masri
TST.V. Sherstneva
T.V. Sherstneva
LKL.B. Kanakhina
L.B. Kanakhina
ЦЕЛЬ ИССЛЕДОВАНИЯ Оценить результаты реконструктивных операций при раке молочной железы путем препекторальной установки имплантатов. МАТЕРИАЛ И МЕТОДЫ В исследование включены 130 пациенток с диагнозом рака молочной железы, у которых на хирургическом этапе лечения выполнена реконструктивно-пластическая операция с одномоментной препекторальной установкой эндопротеза. РЕЗУЛЬТАТЫ Имплантаты с полиуретановым покрытием использованы в 69% случаев, текстурированные имплантаты — в 31% случаев. Чаще всего (в 87% случаев) данная реконструктивная операция выполнялась у пациентов с начальными стадиями заболевания (с 0—IIa стадиями). Химиотерапевтическое лечение после операции получили 62 (47,7%) пациентки. Лучевая терапия проведена в 35 (27%) случаях, из них 60% больных — с установленным полиуретановым имплантатом и 40% больных — с установленным текстурированным имплантатом. В ряде случаев имели место осложнения, которые в большинстве своем были получены на фоне проводимого лучевого и/или химиотерапевтического лечения. ЗАКЛЮЧЕНИЕ Одномоментная реконструкция молочной железы путем препекторального размещения имплантата является надежным и доступным методом реконструкции молочной железы. Очевидно влияние лучевой терапии и химиотерапии на вероятность некоторых видов осложнений. Совершенствование хирургических методик и методов профилактики осложнений позволит в дальнейшем более эффективно использовать препекторальную установку имплантатов для реконструкции молочной железы.

20 December 2023 in Tumors of female reproductive system
Verified
Journal Article
Open access
PDF file
OKO. S. Khodorovich
O. S. Khodorovich
VSV. A. Solodkiy
V. A. Solodkiy
VKV. O. Kleshneva
V. O. Kleshneva
TST. V. Sherstneva
T. V. Sherstneva
KIK. V. Ishchenko
K. V. Ishchenko
КИК. Б. Ищенко
К. Б. Ищенко
Breast cancer continues to maintain a leading position in the structure of the incidence of all oncological diseases among women. Early diagnosis of the disease at the stage of assessing indirect signs makes it possible in the future to maintain a good quality of life for patients by forming proper dynamic monitoring and performing functionally sparing surgical treatment. Interest in the early detection of benign and malignant pathology of the mammary gland is growing every year. A multidisciplinary approach to the study of the formation of breast calcifications makes it possible to look at the problem in a multifaceted way, and ways to solve problems in the process of diagnosis underlie the biochemical understanding of the mechanisms of formation, which is no less important when evaluating mammographic images. Practically up to 50 % of non-palpable breast tumors in practice are detected by signs of existing calcifications in the gland tissue. At present, the problem of early detection of malignant tumors of the breast by radiographic signs of these calcifications, their shape and nature of location in the gland tissue and their further pathomorphological confirmation is being actively studied.We have analyzed the literature data of foreign and domestic authors over the past 20 years. The problem was considered from the mechanism of formation and morphological features of calcifications in the breast tissue to their radiographic assessment on mammographic images. According to the results of the studied literature, the biochemical features of the formations were taken as the basis for understanding the nature of calcifications in the breast tissue. On a biochemical level, calcifications are usually classified into two main types: type I, consisting of calcium oxalate, and type II, consisting of hydroxyapatite. The classification is based on chemical composition and mammographic characteristics, including morphology, distribution and density. Speaking about calcium oxalate, the benign nature of education is most often implied, which cannot be said about hydroxyapatite. Mammography is the main method for diagnosing these formations, taking into account the characteristics of the characteristic radiological signs, which are also detailed in this article.Understanding the molecular and structural development of calcifications may aid in the detection and treatment of breast lesions. Identification of these structures in a patient diagnosed with breast cancer refers to the early diagnosis of the disease, where, with timely prescribed therapy, we get high chances of good long-term results of relapse-free survival.

8 November 2024 in Tumors of female reproductive system
Verified
Journal Article
Open access
PDF file
OKO. S. Khodorovich
O. S. Khodorovich
LKL. B. Kanakhina
L. B. Kanakhina
TST. V. Sherstneva
T. V. Sherstneva
AKA. A. Kalinina-Masri
A. A. Kalinina-Masri
SDSh. M. Dibirova
Sh. M. Dibirova
Background. Breast cancer (BC) stands as one of the most prevalent malignancies affecting women, posing a significant threat to health and life. Timely diagnosis and treatment of BC play a pivotal role in enhancing patient survival rates.Aim. To explore such a method of visualization of BC as mammography and the correlation of its results with the data of histological and immunohistochemical studies, and their significance in planning organ-conserving operations.Materials and methods. The study involved 217 patients diagnosed with nodular BC (T1-2N1M0). AH patients underwent digital mammography, histological examination of biopsy and surgical specimens, and immunohistochemical analysis of tumor tissue (determination of the expression of sex hormone receptors (estrogen and progesterone), HER2/neu status and the status of the Ki-67 marker, reflecting the proliferative activity of tumor cells).Results. Comparison of mammographic and histological/immunohistochemical findings revealed significant differences in tumor visualization among major molecular subtypes of BC. A statistically significant association (p 0.001) was established between carcinoma in situ and radiological features such as spiculated margins and calcifications on mammography.Conclusion. Mammography emerges as an objective and accessible visualization method for BC, enabling assessment of tumor size and peritumoral region. However, for planning breast-conserving surgery for luminal and HER2-positive BC subtypes, a multimodal diagnostic approach is recommended to assess tumor spread, incorporating ultrasound and contrast-enhanced magnetic resonance imaging.

22 April 2025 in Counseling Psychology and Psychotherapy
Verified
Journal Article
Open access
PDF file
BFB.N. Fetisov
B.N. Fetisov
NSN.A. Sirota
N.A. Sirota
OKO.S. Khodorovich
O.S. Khodorovich
ELE.V. Ledin
E.V. Ledin
Background. The achievements of modern medicine can prolong the life of cancer patients. At the same time, the accumulation of a large amount of new unclear or inconsistency information about disease makes it difficult for patients to assess their condition and predict the development of events, which leads to increased uncertainty in illness. Insufficient attention is paid to coping behavior patients conditions of illness with different levels of uncertainty in illness, and the assessment of their effectiveness. Objective. The research is studying coping behavior and levels of anxiety and depression of cancer patients with different levels of uncertainty in illness and treatment duration. Methods. The research included 213 cancer patients aged from 18 to 77 years receiving anticancer drug therapy. There are 115 people with a high level of uncertainty in illness and a shorter period of treatment (“HU”) and 98 people with a moderate level of uncertainty in illness and a longer treatment duration (“MU”). In research we used socio-demographic and clinical questionnaires, Mishel’s uncertainty in illness scale (MIUS-A), the COPE inventory, the world assumptions scale, Treatment-related self-efficacy scale, multidimensional scale of perception of social support (MSPSS), Beck depression inventory, Back anxiety inventory. Results. Patients of “HU” and “MU” groups have different in coping strategies repertoire. “HU” group in compared “MU”-group more often use avoidance coping strategies and that are aimed at regulating emotion. “MU” group more often than “HU” use active coping strategies and strategies that change attitudes to distress. “MU” and “HU” groups have similar basic assumptions about the benevolence of the world and themselves. However, “HU” group in comparison with “MU” — believe they are unlucky and consider that positive and negative life events are not distributed justly. Moreover, they are less confident in their ability to overcome the events related to illness. Both groups of cancer patients feel the greatest social support from their families, and their significant ones. The levels of anxiety and depression were higher in the “HU” group than “MU”.

5 August 2023 in Tumors of female reproductive system
Verified
Journal Article
Open access
PDF file
OKO. S. Khodorovich
O. S. Khodorovich
VSV. A. Solodkiy
V. A. Solodkiy
KAK. S. Astaturyan
K. S. Astaturyan
TST. V. Sherstneva
T. V. Sherstneva
LKL. B. Kanakhina
L. B. Kanakhina
AKA. A. Kalinina-Masri
A. A. Kalinina-Masri
Interest in male breast cancer is increasing every year due to the increase in the spread of this disease. However, the lack of randomized trials in male breast cancer draws the attention of specialists to this problem. Male breast cancer is 100 times less common than female. Over the past decades, there has been an increase in the disease up to 26 %. Low awareness of general practitioners, as well as the male part of the population, untimely access to specialized specialists are the reasons for the late diagnosis of the disease. Recommendations for the treatment of male breast cancer are based on the results of studies conducted in female with a similar diagnosis.In the period from January 2015 to September 2022, 13 patients diagnosed with male breast cancer were examined and treated in the Department of Oncology and Reconstructive Plastic Surgery of the Breast of the Russian Scientific Center of Roentgenradiology, Ministry of Health of Russia. The age of patients at the time of treatment ranged from 58 to 75 years, with a mean age of 63 years. In 2 patients (15 %), stage 0 was established, in 4 (31 %) – stage Ia, in 4 (31 %) – stage IIa, in 1 (7.6 %) – stage IIb, in 1 (7.7 %) – stage IIIb, in 1 (7.6 %) – stage IIIc. Two (15 %) patients underwent neoadjuvant polychemotherapy, 6 (46 %) patients underwent adjuvant polychemotherapy. In 7 (54 %) patients, surgical treatment was performed without further adjuvant polychemotherapy. Six (46 %) patients underwent radiation therapy. Hormone therapy was prescribed to all 13 (100 %) patients. When contacting the clinic, the most frequent complaints would be the appearance of a seal behind the nipple, discharge from the nipple.When diagnosing male breast cancer, the same methods are used as female. Tactics of treatment is determined individually. Early diagnosis of the disease and timely prescribed therapy lead to many years of remission.